-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medicine Network December 25th, in the afternoon of December 24th, Beijing "review the '13th Five-Year' Outlook '14th Five-Year' series of thematic press conference on scientific and technological innovation, Beijing Municipal Science and Technology Commission deputy director, press spokesman Yang Renquan introduced, so far, the country has 5 The new crown vaccine entered Phase III. Clinical, of which Beijing research and development accounted for 4, the country has 5 teams of medium antibody drugs approved clinical, research and development are from Beijing, the city's 9 diagnostic reagent products were approved for market, the number of the first in the country.
Yang Renquan, "13th Five-Year", the city adheres to the people's life and health, strengthen science and technology to support the prevention and control of the epidemic, the people to obtain a sense of well-being and security significantly enhanced. during the
epidemic, Beijing established a war-time mechanism, issued "10" to strengthen the new crown pneumonia science and technology, organized the dominant forces to carry out vaccines, diagnostic reagents, drug research and development, strengthen big data, artificial intelligence and new materials and other technical applications, science and technology to fight the epidemic made important progress.
addition to the outstanding performance of Beijing's scientific and technological innovation in vaccine research and development, the city also supported the development of AI image-assisted diagnostic products, the new crown pneumonia online doctor consultation platform and other new products.
deep use of big data technology to accurately carry out confirmed case traceability, flow and personnel risk identification in and out of Beijing, after the outbreak of new aggregation, only less than 16 hours to accurately target the source of the spread of the outbreak and quickly identify high-risk personnel.
。
